Quinn Opportunity Partners LLC - AVID BIOSERVICES INC ownership

AVID BIOSERVICES INC's ticker is CDMO and the CUSIP is 05368M106. A total of 157 filers reported holding AVID BIOSERVICES INC in Q1 2021. The put-call ratio across all filers is 0.10 and the average weighting 0.3%.

Quarter-by-quarter ownership
Quinn Opportunity Partners LLC ownership history of AVID BIOSERVICES INC
ValueSharesWeighting
Q3 2023$170,203
-32.4%
18,0300.0%0.02%
-35.3%
Q2 2023$251,879
-25.5%
18,0300.0%0.03%0.0%
Q1 2023$338,243
+22.6%
18,030
-10.0%
0.03%0.0%
Q4 2022$275,813
-28.0%
20,0300.0%0.03%
-22.7%
Q3 2022$382,974
+9.1%
20,030
-12.9%
0.04%
+41.9%
Q2 2022$351,000
-25.2%
23,0000.0%0.03%
+55.0%
Q1 2022$469,000
-30.1%
23,0000.0%0.02%
-51.2%
Q4 2021$671,000
-2.8%
23,000
-28.1%
0.04%
-6.8%
Q3 2021$690,000
-20.9%
32,000
-5.9%
0.04%
-18.5%
Q2 2021$872,000
+32.9%
34,000
-5.6%
0.05%
+28.6%
Q1 2021$656,000
+36.1%
36,000
-13.8%
0.04%
+2.4%
Q4 2020$482,000
+51.6%
41,7450.0%0.04%
+20.6%
Q3 2020$318,000
-42.9%
41,745
-50.8%
0.03%
-51.4%
Q2 2020$557,000
+23.8%
84,845
-3.6%
0.07%
+2.9%
Q1 2020$450,000
-73.3%
88,000
-60.0%
0.07%
-38.7%
Q4 2019$1,688,000
+189.5%
220,000
+100.0%
0.11%
+56.3%
Q3 2019$583,000
-31.5%
110,000
-27.6%
0.07%
-33.0%
Q2 2019$851,000
+31.7%
152,0000.0%0.11%
+20.5%
Q1 2019$646,000
+5.0%
152,000
+1.3%
0.09%
+3.5%
Q4 2018$615,000
-40.2%
150,0000.0%0.08%
-41.8%
Q3 2018$1,029,000
+82.8%
150,000
+4.5%
0.15%
+94.7%
Q2 2018$563,000
+56.0%
143,500
+16.2%
0.08%
+63.0%
Q1 2018$361,000123,5000.05%
Other shareholders
AVID BIOSERVICES INC shareholders Q1 2021
NameSharesValueWeighting ↓
AltraVue Capital, LLC 3,302,960$45,481,7586.37%
Sargent Investment Group, LLC 765,096$10,535,3723.27%
AWM Investment Company, Inc. 1,179,826$16,246,2042.34%
Ranger Investment Management 2,164,029$29,798,6792.21%
Parkman Healthcare Partners LLC 428,268$5,897,2501.57%
Redwood Investments, LLC 706,693$9,731,1631.30%
PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. 809,891$11,152,1980.72%
SNYDER CAPITAL MANAGEMENT L P 1,969,441$27,119,2030.61%
Virtus Investment Advisers, Inc. 64,320$885,6860.59%
GENEVA CAPITAL MANAGEMENT LLC 1,836,781$25,292,4750.57%
View complete list of AVID BIOSERVICES INC shareholders